Nektar Therapeutics (NKTR) Shares Outstanding (2011 - 2026)

Nektar Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 127.41% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $29.5 million (up 127.41% YoY), while the FY2025 annual figure was $16.9 million, up 30.4% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $29.5 million, up from $16.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $29.5 million in Q1 2026, with the low at $12.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $12.8 million (2024), against an average of $14.4 million.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) advanced 1.03% in 2024, then soared 127.41% in 2026.
• Nektar Therapeutics' Shares Outstanding (Entity) stood at $12.6 million in 2022, then climbed by 1.5% to $12.8 million in 2023, then increased by 1.4% to $12.9 million in 2024, then jumped by 30.4% to $16.9 million in 2025, then soared by 74.69% to $29.5 million in 2026.
• Business Quant data shows NKTR's Shares Outstanding (Entity) at $29.5 million in Q1 2026, $16.9 million in Q4 2025, and $19.7 million in Q3 2025.